SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies

Chinese Journal of Evidence-Based Medicine

Volumn 10, Issue 5, 2010, Pages 527-533

  Oxman, Andrew D ^a   Lavis, John N ^b   Fretheim, Atle ^a,c   Lewin, Simon ^a,d  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF OSLO   (Norway)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE POLICY; MANAGEMENT; RESEARCH; REVIEW;

EID: 77957319090     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-4505-7-S1-S16     Document Type: Review

References (26)

1. Lavis JN, Oxman AD, Lewin S, et al. SUPPORT Tools for evidenceinformed health Policymaking (STP). Introduction. Health Res Policy Syst, 2009, 7(Suppl 1): I1.
2. Chalmers I. If evidence-informed policy works in practice, does it matter if it doesn't work in theory? Evidence & Policy, 2005, 1: 227-242.
3. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336: 1049-1051.
4. Oxman AD, Fretheim A, Lavis JN, et al. SUPPORT Tools for evidence- informed health Policymaking (STP). 12. Finding and using research evidence about resource use and costs. Health Res Policy Syst, 2009, 7(Suppl 1): S12.
5. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336: 924-926. (Pubitemid 351632017)
6. The SUPPORT Collaboration: How SUPPORT Summaries are prepared 2009 [http://www.support-collaboration.org/summaries/ methods.htm].
7. Lavis JN, Oxman AD, Grimshaw J, et al. SUPPORT Tools for evidence- informed health Policymaking (STP). 7. Finding systematic reviews. Health Res Policy Syst, 2009, 7(Suppl 1): S7.
8. Guyatt G, Oxman A, Kunz R, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and Summary of Findings tables. J Clin Epidemiol, in press.
9. Oxman AD, Lavis JN, Lewin S, et al. SUPPORT Tools for evidence-informed health Policymaking (STP). 10. Taking equity into consideration when assessing the findings of a systematic review. Health Res Policy Syst, 2009, 7(Suppl 1): S10.
10. Akl E, Oxman A, Herrin J, et al. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database of Systematic Reviews, in press.
11. Adily A, Ward J. Evidence based practice in population health: a regional survey to inform workforce development and organisational change. J Epidemiol Community Health, 2004, 58: 455-460.
12. Guyatt GH, Oxman AD, Kunz R, et al. What is "quality of evidence" and why is it important to clinicians? BMJ, 2008, 336: 995-998.
13. Kleijnen J, Gotzsche P, Kunz R, et al. So what's so special about randomisation. In Non-Random Reflections on Health Care Research: On the 25th Anniversary Of Archie Cochrane's Effectiveness and Efficiency Edited by: Chalmers I, Maynard A. London: BMJ Publishers; 1997: 93-106.
14. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ, 1998, 317: 1185-1190. (Pubitemid 28488507)
15. Savedoff WD, Levine R, Birdsall N. When will we ever learn? Improving lives through impact evaluation 2006 [http://www.cgdev.org/files/7973-file- WillWeEverLearn.pdf]. Washington DC, Center for Global Development.
16. Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev, 2009, 1: MR000006.
17. Guyatt GH, Oxman AD, Kunz R, et al. Incorporating considerations of resources use into grading recommendations. BMJ, 2008, 336: 1170-1173. (Pubitemid 351809277)
18. Friedberg M, Saffran B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA, 1999, 282: 1453-1457. (Pubitemid 29493799)
19. Macintyre S, Petticrew M. Good intentions and received wisdom are not enough. J Epidemiol Community Health, 2000, 54: 802-803.
20. Chalmers I. Invalid health information is potentially lethal. BMJ, 2001, 322: 998. (Pubitemid 32374708)
21. Gilbert R, Salanti G, Harden M, et al. Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002. Int J Epidemiol, 2005, 34: 874-887.
22. Oxman AD, Lavis JN, Fretheim A, et al. SUPPORT Tools for evidence-informed health Policymaking (STP). 17. Dealing with insufficient research evidence. Health Res Policy Syst, 2009, 7(Suppl 1): S17.
23. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA, 1990, 263: 2493, 2498, 2501.
24. Stead LF, Lancaster T. Interventions for preventing tobacco sales to minors. Cochrane Database Syst Rev, 2005, 1: CD001497.
25. Kapiriri L, Norheim OF, Martin DK. Priority setting at the micro-, meso- and macro-levels in Canada, Norway and Uganda. Health Policy, 2007, 82: 78-94.
26. Aaserud M, Trommald M, Oxman AD, et al. [Evaluation of reimbursement applications for new drugs]. Tidsskr Nor Laegeforen, 2002, 122: 2619-2623.